{
    "id": "4dfbf0f3-52f5-4461-b645-b8eb8846a8e1",
    "indications": {
        "text": "inrebic\u00ae indicated treatment adult patients intermediate-2 high-risk primary secondary ( post-polycythemia vera post-essential thrombocythemia ) myelofibrosis ( mf ) .",
        "doid_entities": [
            {
                "text": "myelofibrosis (DOID:4971)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4971"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "\u2022 recommended : 400 mg orally daily without food patients baseline platelet count greater equal 50 \u00d7 10 9 /l ( 2.2 ) . \u2022 patients difficulty swallowing capsules whole nasogastric tube , content capsule ( ) may dispersed ensure \u00ae plus ( 2.2 ) . \u2022 reduce dose patients taking strong cyp3a inhibitors severe renal impairment ( 2.3 , 2.4 , 7.1 , 8.6 ) .",
        "doid_entities": [],
        "orphanet_entities": [
            {
                "disease": "severe renal impairment",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_447788"
            }
        ]
    },
    "adverseReactions": "none .",
    "ingredients": [
        {
            "name": "FEDRATINIB HYDROCHLORIDE",
            "code": "UH9J2HBQWJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_36807"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "SODIUM STEARYL FUMARATE",
            "code": "7CV7WJK4UI",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00815"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        }
    ],
    "organization": "Celgene Corporation",
    "name": "Inrebic",
    "effectiveTime": "20250512",
    "indications_original": "INREBIC\u00ae is indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF).",
    "contraindications_original": "\u2022 Recommended Dosage: 400 mg orally once daily with or without food for patients with a baseline platelet count of greater than or equal to 50 \u00d7 10 9 /L ( 2.2 ). \u2022 For patients who have difficulty swallowing capsules whole or those with a nasogastric tube, the content of the capsule(s) may be dispersed in Ensure \u00ae Plus ( 2.2 ). \u2022 Reduce dose for patients taking strong CYP3A inhibitors or with severe renal impairment ( 2.3 , 2.4 , 7.1 , 8.6 ).",
    "adverseReactions_original": "None.",
    "drug": [
        {
            "name": "Inrebic",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_36807"
        }
    ]
}